Concord Biotech Limited has informed the Exchange about Copy of Newspaper Publication

CONCORDBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+12.3%1-day move

₹1050.60

prior close

₹1047.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.5-0.4-1.7+12.3+13.8+17.6+16.6+13.6+25.6+27.1+22.5——

Up moveDown movePending

AI summary

Concord Biotech Limited has submitted a copy of newspaper publications containing extracts of their audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The results were published on May 30, 2026 in Financial Express (English - All editions) and Financial Express (Gujarati - Ahmedabad edition). This filing is pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed companies to publish their quarterly and annual financial results in newspapers. The full financial results are also available on the company's website.

Likely market impact

This is a routine regulatory compliance filing confirming that Concord Biotech has publicly disclosed its Q4 and FY 2026 financial results as required by SEBI regulations. Shareholders should refer to the full financial results for detailed performance metrics.